Nivelles (Belgium) / Kuala Lumpur, Malaysia – [March 17, 2026] – Quantoom Biosciences, a full-stack RNA partner providing turnkey solutions for mRNA- and saRNA-based vaccines and therapeutics, today announced a distribution partnership with Chemopharm (Malaysia) to expand access to Ntensify® mano and Ntensify® micro RNA production systems across Malaysia’s life-science and biotech research sectors.
Under this agreement, Chemopharm will market and distribute Quantoom’s bench-scale Ntensify solutions, enabling researchers and biotech innovators to produce high-quality mRNA with streamlined workflows and reduced operational complexity.
Expanded access to RNA production technologies
Ntensify® mano is an integrated mRNA production and purification kit designed to deliver up to 3 mg of purified mRNA in under half a day with all reagents and components included, supporting accelerated research workflows. (https://quantoom.com/ntensify-mrna-production-solution/mrna-production-kit/)
Ntensify® micro is a compact RNA production platform capable of producing and purifying 200 μg to 100 mg of high-quality mRNA in under 3 hours, with optional compatibility for high-throughput formats.
(https://quantoom.com/ntensify-mrna-production-solution/ntensify-micro-mrna-production-system/)
Quotes
José Castillo, CEO of Quantoom Biosciences, said:
“Partnering with Chemopharm strengthens our regional distribution footprint and helps bring trusted, user-friendly RNA production technologies to Malaysia’s research community. Ntensify mano and micro empower scientists to move efficiently from design to high-quality mRNA output.”
Robin Chew, Vice President, Analytical & Life Science of Chemopharm, said:
“We are excited to include Quantoom’s Ntensify solutions in our product portfolio. These technologies align with our mission to support local researchers with advanced, reliable tools that accelerate scientific progress and enable innovation in RNA-based research.”
Availability and support
Chemopharm will provide local commercial and technical support, including product access, onboarding, and first-line assistance for Ntensify solutions throughout Malaysia. Researchers and biotech teams can contact Chemopharm (+603-78726000, enquiry@chemopharm.com) or Quantoom for further information.
About Quantoom Biosciences
Quantoom Biosciences is a full-stack RNA partner providing turnkey solutions for mRNA- and saRNA-based vaccines and therapeutics, covering the full workflow from sequence design to RNA production and LNP formulation. It’s mission is to provide any player of the life-science.biotech sector with tools to rapidly translate their science into life-changing RNA medicine.
Its N-Force toolbox relies on 3 core elements to turn any antigen into a (sa)mRNA-LNP drug product: Ncode for sequence design and optimization, Ntensify® for RNA production and Ncapsulate® for RNA-LNP formulation. Launched in 2023, the Ntensify solution enables fully integrated, scalable RNA production by combining processes, equipment, reagent mixes, and disposables and has gained global adoption, being recognized for performance and ease-of-use. Beyond technology, Quantoom Biosciences assists its partners by providing extensive enabling solutions, ranging from strategic R&D partnerships to sequence design & optimization.
For more information about Quantoom Biosciences, visit www.quantoom.com.
About Chemopharm (Malaysia)
Chemopharm (Malaysia) is a pharmaceutical and life-science solutions provider offering a broad portfolio of laboratory products, chemicals, reagents, and equipment to support research, quality control, and production environments. With a focus on technical expertise and responsive customer support, Chemopharm serves academic, industrial, and clinical laboratories across Malaysia. (https://www.chemopharm.com/about-us/)